Blood based Colon Cancer Screening – NEJM papers – ECLIPSE – Guardant
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
A re-analysis of the SWOG S1801 trial (neoadjuvant pembrolizumab versus adjuvant only), and more…
By Nausheen Ahmed, Olalekan Oluwole & 3 more. We recommend re-immunizing patients post CAR-T based on CDC and transplant guidelines.
Some doctors are promoting propellant-free inhalers over puff inhalers that emit greenhouse gases. Climate change can exacerbate respiratory ills because of more fires, air pollution…
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
Mayo Clinic’s PragMMatic Study Accruing Newly Diagnosed Multiple Myeloma Patients A new clinical trial administered by the Mayo Clinic, the PragMMatic Study, is now accruing newly…
TPS9605 Background: Adjuvant treatment with anti-PD1 therapy improves the recurrence free survival (RFS) in resectable stage III melanoma. The Checkmate-238 and KEYNOTE-054 trials respectively reported…
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
The OncoAlert Newsletter is now out for June 23-29, 2023
In a pair of Special Reports, Gökbuget and colleagues present updated European Leukemia Net (ELN) consensus reports on (1) the diagnosis, prognostic factor
‘Boring Milner’ and ‘Andy Robson’ accounts work with Fanwave Digital, a firm paid by Paddy Power Betfair to post betting tips